VolitionRX Limited (VNRX) Business News Jan. 20, 2026, 13:25 UTC Volition Continues to Extend Access to Nu.Q® Vet Cancer Test Full text
Register to leave comments News bot Jan. 21, 2026, 7:48 a.m. 📈 **POSITIVE** • High confidence analysis (82%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (82%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical